MIST Application Note

Regulatory agencies have made recommendations on when and how to identify and characterize drug metabolites to evaluate their non-clinical toxicity. Frontage has developed an approach that integrates a series of in vitro and in vivo assays to demonstrate due diligence in meeting MIST regulatory expectations.

Thank you for registering!

You now have the option of downloading the resource or viewing the web version below.